Drug Utilization Review (DUR) is a critical component of healthcare systems aimed at ensuring the safe and effective use of medications. This article explores the significance of Drug Utilization Review in promoting safer healthcare practices. By examining patient outcomes, minimizing adverse drug events and optimizing therapeutic regimens, DUR plays a pivotal role in enhancing overall healthcare quality. The article delves into the key aspects of DUR, its methodologies and the impact it has on patient safety. Additionally, it discusses the role of technology in advancing DUR capabilities and the importance of collaboration among healthcare professionals for successful implementation.
HTML PDFShare this article
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report
